Entry into the Program: Fall 2019
Pronouns: She/Her
Advising Professor(s): Dr. Carolyn Brown
Education
- MPH, Columbia University
- B.A. Anthropology, Amherst College
Research Interests
- Clinical Outcomes, Economic Evaluation, Health Disparities/Health Equity, Health Policy & Regulation, Social Determinants of Health
Publications
- Briggs O., Sakthisivabalan L., Brown, C., Johnsrud, M. [Abstract] The Use of Real-World Evidence to Support FDA Orphan Drug Approvals: A Narrative Review. National Organization for Rare Disease. October 2023.
- Miller SD, Lozano-Ortega G, Mutebi A, et al. Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma [published online ahead of print, 2022 Nov 23]. Journal of Comparative Effectiveness Research. 2022;10.2217/cer-2022-0146. doi:10.2217/cer-2022-0146
- Gugala E., Briggs O., Moczygemba L., Brown C., Hill L. 2021. [Manuscript] Opioid Harm Reduction: A Scoping Review of Physician and System-Level Gaps in Knowledge, Education, and Practice. Substance Abuse. doi.org/10.1080/08897077.2022.2060423.
- Stein E., Bonifacio G., Latremouille-Viau D., Guerin A., Shi S., Gagnon-Sanschagrin P., Briggs O., Joseph G. 2018. [Manuscript] Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Acute Myeloid Leukemia in Commercially Insured and Medicare Populations. Journal of Medical Economics. 21(6): 556-563.
- Stein E., Bonifacio G., Latremouille-Viau D., Guerin A., Shi S., Gagnon-Sanschagrin P., Briggs O., Joseph G. 2017. [Abstract] Real-World Treatment Patterns and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia. Journal of Managed Care & Specialty Pharmacy. Vol. 23 (3a): S34.
- Richie E., Wolff J., Latremouille-Viau D., Guerin A., Pivneva I., Briggs O., Joseph G. 2017. [Abstract] Tyrosine Kinase Inhibitor (TKI) Therapy Discontinuation in Patients with CML in Chronic Phase: A US Clinical Practice Perspective. Journal of Clinical Oncology. 7052.
Presentations
- Briggs O., Sakthisivabalan L., Brown, C., Johnsrud, M. The Use of Real-World Evidence to Support FDA Orphan Drug Approvals: A Narrative Review. National Organization for Rare Disease Summit, October 2023.
- Briggs O., Mwanzaa, B., Teng, E. Navigating the Impact of COVID and State Violence in the Workplace. Amherst College, June 2022.
- Miller SD, Lozano-Ortega G, Mutebi A, et al. Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma. J Comp Eff Res. 2022;10.2217/cer-2022-0146. doi:10.2217/cer-2022-0146.
- Gugala E., Briggs O., Moczygemba L., Brown C., Hill L. Opioid Harm Reduction: A Scoping Review of Healthcare Professional and System-Level Gaps in Knowledge, Education, and Practice. American Pharmacist Association Annual Meeting, March 2021.
Internship/Graduate Research Assistantship
- NCCN/Pfizer Graduate Research Assistant, “Biosimilar Optimization in Community Oncology Practice
Contact Information
Why UTCOP HOD?
- UTCOP is home to a renown Health Outcomes program, filled with diverse faculty members and students with extensive research interests and career goals.
What do you enjoy outside of school?
- Outside of school, I enjoy exploring Austin's scenic park trails and live music performances.